Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

8.3K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photocatalytic Markovnikov-Selective Sulfonation of Alkynes for Indoline Synthesis.

The Journal of organic chemistry·2026
Same author

The genome and transcriptome of Musa itinerans unveil novel candidate genes for fusaric acid resistance.

The Plant journal : for cell and molecular biology·2026
Same author

Correction to: Impact of Mandatory Clinical Ethics Consultation for Neurocritically Ill Patients.

Journal of bioethical inquiry·2026
Same author

Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.

Annals of clinical and laboratory science·2026
Same author

Comparison of the effectiveness of neoadjuvant chemotherapy versus upfront surgery for osteosarcoma: A target trial emulation study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Porphyromonas gingivalis lipopolysaccharide promotes peri-implant inflammation through neutrophil activation.

Journal of prosthodontic research·2026

Related Experiment Video

Updated: Jan 17, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
12:09

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

22

A TP53 Intron-Derived Peptide Promotes Tumor Survival.

Louis A Cadena, Kevin Lee Luo, Cristian A Otero-Perez

    Biorxiv : the Preprint Server for Biology
    |September 18, 2025
    PubMed
    Summary

    Leukemia cells utilize intronic alternative polyadenylation (IPA) to create a novel peptide, IDP1, from the TP53 gene. This oncogenic peptide enhances cancer cell survival independently of p53 function.

    More Related Videos

    Yeast As a Chassis for Developing Functional Assays to Study Human P53
    14:57

    Yeast As a Chassis for Developing Functional Assays to Study Human P53

    Published on: August 4, 2019

    10.0K
    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    3.9K

    Related Experiment Videos

    Last Updated: Jan 17, 2026

    Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
    12:09

    Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

    Published on: December 30, 2025

    22
    Yeast As a Chassis for Developing Functional Assays to Study Human P53
    14:57

    Yeast As a Chassis for Developing Functional Assays to Study Human P53

    Published on: August 4, 2019

    10.0K
    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
    09:15

    Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

    Published on: February 24, 2023

    3.9K

    Area of Science:

    • Molecular Biology
    • Cancer Research
    • Genomics

    Background:

    • Alternative cleavage and polyadenylation (APA) generates transcript variants with different 3' ends.
    • Leukemia cells exploit intronic APA (IPA) to produce shorter RNA isoforms, impacting tumor suppressor gene expression.
    • Many long non-coding RNAs generated by IPA in leukemia remain uncharacterized.

    Purpose of the Study:

    • To investigate non-coding IPA isoforms in the TP53 gene.
    • To characterize a novel peptide derived from an IPA isoform of TP53.
    • To elucidate the functional role of this novel peptide in leukemia.

    Main Methods:

    • Utilized a custom antibody to detect the novel peptide.
    • Employed proteomic approaches and functional studies.
    • Investigated effects on cell viability, apoptosis, cell cycle, and DNA damage response.

    Main Results:

    • Identified a non-coding IPA isoform of TP53 producing a peptide termed IDP1 (IPA-Derived Protein 1).
    • IDP1 expression observed in leukemia patients and cell lines.
    • IDP1 demonstrated an oncogenic role, enhancing cell survival during drug treatment and promoting tumor formation in vivo.
    • IDP1 regulates cell viability through apoptotic signaling, cell cycle, and DNA damage response pathways, independently of direct p53 interaction.

    Conclusions:

    • Alternative RNA isoforms can possess functions independent of their parent genes.
    • IPA can lead to the gain of novel gene products and functions, not just gene truncation.
    • IDP1 represents a functionally distinct product of the TP53 locus with oncogenic potential in leukemia.